Teva Pharma (TEVA) Tops Q1 EPS by 11c

Go back to Teva Pharma (TEVA) Tops Q1 EPS by 11c

Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 30

April 30, 2015 7:02 AM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

... More

Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 29

April 29, 2015 5:28 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More